Errata by unknown
Turner N, Hariharan K, TidAng J, Frangioudakis G, Beale SM, Wright LE, Zeng XY, Leslie SJ, Li J-Y, Kraegen
EW, Cooney GJ, Ye J-M. Enhancement of muscle mitochondrial oxidative capacity and alterations in insulin
action are lipid species dependent: potent tissue-speciﬁc effects of medium-chain fatty acids. Diabetes
2009;58:2547–2554
In the print version of the article listed above, in Table 2, the units for the muscle and liver triglycerides are incorrect.
The correct units are mol/g. The online version reﬂects these changes.
Basu R, Basu A, Grudzien M, Jung P, Jacobson P, Johnson M, Singh R, Sarr M, Rizza RA. Liver is the site of
splanchnic cortisol production in obese nondiabetic humans. Diabetes 2009;58:39–45
The authors of the article listed above have erroneously used the intravenous ICG infusion rate (in g/min) and the
arterial-portal ICG concentration difference to calculate portal venous blood ﬂow. Because the liver is the sole source
of clearance of ICG, the ICG infusion rate is appropriate for calculation of splanchnic blood ﬂow but not for
determination of portal blood ﬂow. The authors conﬁrm that this error does not inﬂuence the main conclusion of the
article that the viscera do not produce cortisol. Based on previous data, one can assume portal blood ﬂow to be
80–90% of splanchnic blood ﬂow, allowing extrahepatic splanchnic exchange to be estimated using assumed rather
than measured portal blood ﬂow. Such an estimate gives a result similar to that reported in the study. Moreover, the
authors’ conclusion is in fact independent of portal blood ﬂow because it depends solely on the lack of dilution of D4
cortisol (i.e., lack of change in molar enrichment) between arterial and portal venous blood for either total cortisol or
D3 cortisol.
ERRATA
diabetes.diabetesjournals.org DIABETES, VOL. 59, MAY 2010 1283